Bandingkan Harga & Kinerja Esa Medika Mandiri Tbk. (EMMI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Esa Medika Mandiri Tbk. dan Organon Pharma Indonesia Tbk.: Esa Medika Mandiri Tbk. diperdagangkan di Rp348 (kapitalisasi pasar 627,43 M, volume 24 jam 1,49 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Esa Medika Mandiri Tbk. jauh lebih besar — sekitar 6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EMMI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 627,43 M | 104,4 M |
Volume | 1,49 jt | — |
Lot | 14,86 rb | — |
Perputaran | 522,06 jt | — |
Harga Rata-rata | 351,42 | — |
Nilai Transaksi | 522,06 jt | — |
Harga Ekuilibrium Indikatif | 348 | — |
Volume Ekuilibrium Indikatif | 1,55 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Esa Medika Mandiri Tbk.
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Selengkapnya di halaman EMMI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
